Western blot analysis showed that (R)-ketamine (10 mg/kg) significantly improved the reduced levels of BDNF and TGF-β1 in the PFC from CRS-exposed mice, and attenuated the increased expression of MeCP2 (Fig. 3A–C). Here, MECP2 is linked to congenital rubella syndrome.